JPMorgan Chase & Co. Lowers Omada Health (NASDAQ:OMDA) Price Target to $26.00

Omada Health (NASDAQ:OMDA) had its price objective cut by equities researchers at JPMorgan Chase & Co. from $32.00 to $26.00 in a research note issued on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 78.94% from the company’s current price.

A number of other equities analysts have also commented on OMDA. The Goldman Sachs Group reiterated a “buy” rating and issued a $26.00 price objective on shares of Omada Health in a report on Friday, January 16th. Wells Fargo & Company assumed coverage on Omada Health in a research report on Thursday, January 8th. They set an “equal weight” rating and a $17.00 target price on the stock. Weiss Ratings reiterated a “sell (d)” rating on shares of Omada Health in a research note on Thursday, January 22nd. Canaccord Genuity Group decreased their price target on shares of Omada Health from $28.00 to $22.00 and set a “buy” rating for the company in a research report on Friday, March 6th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $28.00 price target on shares of Omada Health in a report on Thursday, January 22nd. Eight analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $23.60.

Omada Health Trading Up 3.6%

NASDAQ OMDA opened at $14.53 on Thursday. The business’s 50-day moving average price is $13.89 and its 200 day moving average price is $18.44. Omada Health has a twelve month low of $10.28 and a twelve month high of $28.40. The company has a market capitalization of $856.18 million and a PE ratio of -85.47.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, March 5th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.12. The firm had revenue of $75.85 million during the quarter.

Insider Buying and Selling at Omada Health

In related news, CEO Sean P. Duffy sold 230,479 shares of the stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $15.60, for a total value of $3,595,472.40. Following the completion of the sale, the chief executive officer owned 126,644 shares in the company, valued at approximately $1,975,646.40. This trade represents a 64.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Wei-Li Shao sold 5,618 shares of Omada Health stock in a transaction that occurred on Monday, December 29th. The stock was sold at an average price of $16.13, for a total value of $90,618.34. Following the sale, the president directly owned 69,079 shares in the company, valued at $1,114,244.27. The trade was a 7.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 280,956 shares of company stock valued at $4,395,050.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in OMDA. Quarry LP bought a new position in shares of Omada Health in the 4th quarter worth $29,000. TD Waterhouse Canada Inc. acquired a new position in Omada Health in the 4th quarter worth $32,000. Raymond James Financial Inc. acquired a new stake in shares of Omada Health in the 2nd quarter valued at about $32,000. Strs Ohio bought a new position in shares of Omada Health during the third quarter worth about $38,000. Finally, Inlight Wealth Management LLC acquired a new position in Omada Health during the fourth quarter worth $45,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.